Psychedelics: Has Nature Given Us All We Need?

Mar 15, 2022

2:30pm – 3:30pm CT

Is Mother Nature’s psychedelic toolkit of naturally occurring compounds such as psilocybin, DMT, 5-MeO-DMT and mescaline sufficient as therapies for the emerging psychedelic healthcare movement? Or is there ample room for improvement with “Generation 3” compounds that are are inspired by existing psychedelic scaffolds but nonetheless man-made, synthesized in a lab and potentially more commercially viable? There’s an ongoing debate between pure plant-derived medicine vs. chemically synthesized compounds and which has better therapeutic potential to address mental health disorders and other conditions. This panel seeks to address many of these hot button issues and provide a mechanistic and pharmacological perspective on psychedelic compounds and their analogues.

Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.

John McCorvy

Medical College Of Wisconsin

Charles Nichols, PhD

LSU Health Sciences Center

Tim Schlidt

Palo Santo

This event will be in person


Primary Entry:
Platinum Badge
Interactive Badge
Secondary Entry:
Music Badge
Film Badge





Health & MedTech track sponsored by Optum


The State of Psychedelics summit sponsored by Vine VC